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Arrhythmogenic cardiomyopathy (AC) has originally been described as a disorder
characterized by fibrofatty replacement of the myocardium, primarily of the right ventricle
(RV), and ventricular tachyarrhythmias, sudden death, and at a late stage progressive
heart failure. Arrhythmogenic right ventricular dysplasia or cardiomyopathy (ARVD/C) was
the previous name of the disease. However, similar histopathologic changes are also
found in the left ventricle (LV). AC is also considered a hereditary disease. Recent
molecular genetic studies provide accumulating evidence that fibrofatty replacement is
preceded by mutation-related desmosomal changes. Desmosomal dysfunction may lead
to mechanical and thereafter electrical uncoupling, ultimately resulting in conduction
delay. This activation delay and conduction block, provide a substrate for re-entrant
mechanisms and thereby ventricular tachycardia (VT). The gold standard for AC diagnosis is
demonstration of transmural fibrofatty replacement in cardiac tissue obtained by autopsy
or surgery. To facilitate diagnosis in clinical practice, an international Task Force defined
in 1994 a set of criteria (TFC) based on electrocardiographic, functional and morphologic
features, and family history. These criteria have recently been revised. Routine 12-lead
electrocardiography is one of the most important tools for AC diagnosis in all stages of
the disease. Even in the absence of other markers in the early concealed stage of the
disease, in line with early slow conduction and electrical uncoupling ECG analysis may
contribute to early diagnosis. Activation delay and site of origin of VT are reflected in
various characteristics of the surface 12-lead electrocardiogram. Since the ECG is easy to
obtain, this technique is particularly useful, for both diagnosis and follow up of disease
progression.
Keywords: electrocardiography, diagnosis, ventricular tachycardia, cardiomyopathy, arrhythmogenic right
ventricular dysplasia
INTRODUCTION
Arrhythmogenic cardiomyopathy (AC) has originally been
described as a disorder histopathologically characterized by fibro-
fatty replacement of the myocardium, primarily of the right
ventricle (RV), and clinically by ventricular tachyarrhythmias,
sudden death, and at a late stage progressive heart failure (Marcus
et al., 1982; Basso et al., 1996, 2009; Roguin et al., 2004; Dalal
et al., 2005; Piccini et al., 2005; Cox et al., 2008). Arrhythmogenic
right ventricular dysplasia or cardiomyopathy (ARVD/C) was the
previous name of the disease. However, similar histopathologic
changes are also found in the left ventricle (LV). Moreover, at
the molecular level both ventricles and also the interventricular
septum are equally affected by down-regulation and altered dis-
tribution of intercalated disk proteins. These observations made
AC the preferred terminology.
AC is also considered a hereditary disease. Recent molec-
ular genetic studies provide accumulating evidence that fibro-
fatty replacement is preceded by mutation-related desmosomal
changes (McKoy et al., 2000; Protonotarios et al., 2001; Rampazzo
et al., 2002; Gerull et al., 2004; Dalal et al., 2006; Pilichou et al.,
2006; Syrris et al., 2006a,b; den Haan et al., 2009; Cox et al.,
2011). Desmosomes are protein complexes located in the interca-
lated disk between adjacent cells and are crucial for maintaining
mechanical coupling of the cardiomyocytes. Several reports have
shown that alterations in one or multiple desmosomal proteins
affect expression and distribution of other desmosomal and other
non-desmosomal intercalated disk proteins, such as Connexin43
and the sodium channel Nav1.5, responsible for electrical cou-
pling and conduction, respectively (Oxford et al., 2007; Sato et al.,
2009). In this way mechanical uncoupling gives rise to electrical
uncoupling and slow conduction (Kaplan et al., 2004a,b; Oxford
et al., 2007; Asimaki et al., 2009; Noorman et al., 2009; Sato et al.,
2009).
The relationship between this mechanical and electrical
uncoupling and fibrofatty replacement is largely unknown.
However, the hypothesis that in AC patients cardiac cellular
uncoupling precedes fibrofatty alteration is strongly supported by
identification of an altered distribution of desmosomal proteins
and Connexin43, in histologically still unaffected left ventricu-
lar and septal tissue (Asimaki et al., 2009). This observation may
have diagnostic implications in the early concealed stage of the
disease, characterized by still absent or minor histopathological
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tissue alteration. However, sudden death may occur at that stage
as first manifestation of AC (Thiene et al., 1988; Corrado et al.,
1997). Slow conduction and electrical uncoupling and at a later
stage altered tissue architecture due to the fibrofatty infiltration,
lead to inhomogeneous activation delay by electrical conduction
block, lengthening of conduction pathways, and load mismatch
at pivotal points. This activation delay and conduction block,
provide a substrate for re-entrant mechanisms and thereby ven-
tricular tachycardia (VT) (Spear et al., 1979; de Bakker et al., 1993;
Cabo et al., 1994; Fast and Kléber, 1997; Kaplan et al., 2004a,b).
Previous invasive electrophysiologic studies have confirmed that
VT in patients with AC is due to reentry (Ellison et al., 1998;
Marchlinski et al., 2004).
Why fibrofatty alteration is usually more prominent in the
RV is still unclear. A larger stretch at the thin RV wall has been
suggested as a potentially causative factor (Basso et al., 2009).
A histologically dominant RV involvement seems to be related
to a frequently observed right ventricular origin of monomor-
phic VT, showing left bundle branch block (LBBB) morphology.
Studies on the origin of polymorphic VT and ventricular fibrilla-
tion are lacking. Both ventricles are not homogeneously affected.
Marcus et al. described already in 1982 the so-called “triangle of
dysplasia,” being the RV outflow tract, an area below the tricus-
pid valve, and the RV apex (Marcus et al., 1982). However, other
areas in the RV, as well as the LV may be affected. Histologically
and in imaging studies septal involvement is not common in
AC. However, septal fibrosis is frequently found with cardiac
sarcoidosis. Clinically, cardiac sarcoidosis can mimic the AC
phenotype as well (Ladyjanskaia et al., 2010). The differential
diagnosis of AC versus cardiac sarcoidosis is crucial since man-
agement in both diseases is very different (Ladyjanskaia et al.,
2010).
The gold standard for AC diagnosis is demonstration of
transmural fibrofatty replacement in cardiac tissue obtained by
autopsy or surgery. To facilitate diagnosis in clinical practice, an
international Task Force defined in 1994 a set of criteria (TFC)
based on electrocardiographic, functional and morphologic fea-
tures, and family history (McKenna et al., 1994). Data of growing
numbers of index cases and their familymembers, combined with
molecular genetic data, increased insight in development and
behavior of the disease process importantly (Hulot et al., 2004;
Dalal et al., 2006; Cox et al., 2011). Therefore, recently a new Task
Force introduced modifications to the 1994 TFC by implementa-
tion of these new insights (Marcus et al., 2010). Similar as in the
1994 TFC, also in the new TFC abnormalities were subdivided
into major and minor according to the specificity for AC. AC
diagnosis was based on the combination of either two major cri-
teria, or onemajor and two minor, or four minor criteria. Criteria
were derived from: (1) global or regional dysfunction and struc-
tural alterations, (2) tissue characterization, (3) depolarization
abnormalities, (4) repolarization abnormalities, (5) arrhythmias,
and (6) family history.
Routine 12-lead electrocardiography is one of the most
important tools for AC diagnosis in all stages of the disease. Even
in the absence of other markers in the early concealed stage of
the disease, in line with early slow conduction and electrical
uncoupling ECG analysis may contribute to early diagnosis.
Activation delay and site of origin of VT are reflected in various
characteristics of the surface 12-lead electrocardiogram. Since the
ECG is easy to obtain, this technique is particularly useful, not
only for AC diagnosis, but also for evaluation of disease progres-
sion during follow-up. In addition, 12-lead ECG recording of a
specific VT morphology is crucial to select and map the VT for
catheter ablation procedures.
TWELVE-LEAD ECG DURING NORMAL SINUS RHYTHM
ACTIVATION DELAY (DEPOLARIZATION) PARAMETERS
Activation delay due to cellular uncoupling and slow conduc-
tion, and altered tissue architecture by fibrofatty replacement
is often visible in the ECG. In the original descriptions and
1994 TFC, typical manifestations are epsilon waves and widen-
ing of the QRS complex in leads V1–V3 (McKenna et al., 1994).
Epsilon waves and localized QRS prolongation are major crite-
ria of the 1994 TFC. An epsilon wave was defined as a distinct
deflection after the end of the QRS complex, i.e., after the QRS
complex had returned to the isoelectric line (Figure 1) (Fontaine
et al., 1993). In the new TFC the epsilon wave remained as
a major criterion, but the widening of the QRS complex was
deleted, since discrimination from right bundle branch block
(RBBB) may be difficult. Although epsilon waves are highly spe-
cific for AC, sensitivity is low. Cox et al. (Cox et al., 2008)
observed an epsilon wave in only 4 out of 42 AC patients (10%).
Because of this limited sensitivity, other parameters have been
evaluated.
Peters et al. (Peters and Trummel, 2003) determined increased
QRS ratio by using the QRS duration of all precordial leads
in the formula (V1 + V2 + V3)/(V4 + V5 + V6) > 1.2 to solve
the problem of discrimination with RBBB. However, also this
criterion was found in only 35% of patients with AC (Cox
et al., 2008). Nasir et al. reported the delayed S wave upstroke
defined from the nadir of the S wave up to the isoelectric line
in V1−3 ≥ 55ms, as a sensitive criterion representing activation
delay (Nasir et al., 2004).
Our group introduced prolonged Terminal Activation
Duration (TAD) (Cox et al., 2008). TAD is defined as the longest
value in V1−3, from the nadir of the S wave to the end of all
depolarization deflections, thereby including not only the S wave
upstroke, but also both late fractionated signals and epsilon waves
(Figure 2). Thus, total activation delay was conveyed by this new
parameter. In Figure 2, the difference between S wave upstroke
and TAD is clearly visible. TAD was considered prolonged if
≥55ms, and only applicable in the absence of complete RBBB.
The same value was applied as determined for prolonged S wave
upstroke by Nasir et al. (2004) since it proved to be a cut-off
point with high specificity also in our study. Prolonged TAD
appeared to be the most sensitive activation delay criterion. It
was recorded in 30 of 42 AC patients (71%). Prolonged TAD was
not identified in 26 of 27 patients with idiopathic VT (Figure 3).
Because of the superiority in sensitivity and the high specificity
of prolonged TAD, this new criterion was included in the new
2010 TFC (Marcus et al., 2010). Cox et al. reported recording of
prolonged TAD in 5 out of 16 young (age<20 years) relatives of a
pathogenic mutation-carrying proband with AC. In four of them
it was the only identified abnormality. These findings suggest that
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FIGURE 1 | Epsilon waves in precordial leads V1−3 from AC patient with plakophilin2 mutation. Epsilon wave is a distinct deflection clearly separated
from QRS complex. Epsilon wave remains a major criterion in the new Task Force criteria.
FIGURE 2 | ECG recordings V1 and V2 of 4 patients in sinus rhythm,
while off drugs (25mm/s, low-pass filter 100Hz). RBBB was absent
(RBBB defined as QRS duration ≥120ms in all leads). Difference in
measurement results (in ms) of S wave upstroke (1st complexes, dashed
lines) and terminal activation duration (TAD; 2nd complexes, continuous
lines). Panel A (control patient) shows no differences in S wave upstroke
and TAD, both being normal. On the contrary, in panels B–D (AC patients),
S wave upstroke <55ms, whereas TAD is prolonged. Prolonged TAD is a
minor criterion in the new Task Force criteria. [Reprint with permission from
Cox et al. (2008)].
prolonged TAD is an important marker in the early identification
of AC.
It has to be realized that these diagnostic criteria use only V1−3,
facing the RV outflow tract. Therefore, all criteria mentioned
FIGURE 3 | Results of measurements of terminal activation duration
(TAD) of AC patients and idiopathic VT controls. Mean values are
indicated by horizontal lines. AC patients had a significantly longer TAD than
idiopathic VT control patients (P < 0.001). The dashed line indicates the
cut-off point of 55ms. [Reprint with permission from Cox et al. (2008)].
might reflect activation delay primarily of this part of the RV.
Other still undefined criteria are needed to reflect alterations in
other parts of the right and also LV.
REPOLARIZATION PARAMETERS
Abnormalities in repolarization in patients with AC are recorded
as inverted T waves. In the 1994 TFC, inverted (negative) T
waves in V1−3 or beyond were considered a minor criterion for
AC diagnosis in the absence of RBBB and only if the patient
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was older than 12 years (Figures 1, 4). Because of the high
specificity for AC, this criterion was upgraded to a major cri-
terion in the new TFC, for individuals older than 14 years of
age and in the absence of complete RBBB. In our series of
42 AC patients, this criterion was met in 28 patients (67%)
and in none of the patients with idiopathic VT (Cox et al.,
2008). Thus, sensitivity and specificity are similar to prolonged
TAD.
In the new TFC, 3 additional criteria were included as minor
criteria:
1. Inverted T waves only in leads V1−2 in individuals older than
14 years of age and in the absence of complete RBBB (Marcus
et al., 2010). This criterion was identified in 4 of our 42
patients (10%) (Cox et al., 2008).
2. Inverted T waves only in V4−6.
3. Inverted T waves in leads V1−4 in individuals older than
14 years of age in the presence of RBBB (Marcus et al., 2010).
This criterion was added since RBBB may be due to local acti-
vation delay and a negative T wave in V4 and beyond is very
unlikely in classic RBBB.
TWELVE LEAD ECG DURING VT
VT PARAMETERS FOR DIAGNOSIS AND LOCALIZATION OF SITE
OF ORIGIN
VT morphology and number of VT morphologies reflect loca-
tion and extent of the disease process. In the absence of severe
left ventricular and septal structural disease, a VT with LBBB
morphology (dominant negativity in V1) means a site of origin
in the RV. This is why AC is associated with monomorphic VT
with LBBB morphology. In the 1994 TFC, recording of this VT
morphology was a minor criterion for AC diagnosis (McKenna
et al., 1994). However, we hypothesized that additional infor-
mation could be obtained if the axis of the VT was taken into
account.
Idiopathic VT originating from the RV outflow tract, always
shows LBBB morphology with an inferior axis. In contrast, in
AC, affected areas are also found in other parts of the RV.
Consequently, VT episodes originating from these areas can show
LBBB morphology with a non-inferior axis as well. We evaluated
the occurrence of LBBB VT with a superior axis arbitrarily
defined from −30◦ to −150◦ (Figure 5) (Cox et al., 2008). This
morphology was recorded in 27 of 42 patients (64%) with AC
diagnosed according to the 1994 TFC. None of the 27 patients
with idiopathic VT had this morphology. Thus, also this crite-
rion had a similar specificity and sensitivity as prolonged TAD
(≥55ms) and negative T waves in V1−3. In accordance with our
definition, recording of a VT with LBBB morphology and supe-
rior axis, defined as negative or indeterminate QRS in leads II, III,
and aVF, and positive in lead aVL, became a major criterion in
the new TFC (Marcus et al., 2010). A VT with LBBB morphol-
ogy and inferior axis remained a minor criterion (Figure 6). The
number of premature ventricular complexes on Holter monitor-
ing required for counting as a minor criterion, decreased to 500
per 24 h.
Because of the variable extent of the disease process in AC,
the number of VT morphologies may vary as well. Thus, mul-
tiple VT morphologies may be recorded in a single patient.
Previous studies showed mean numbers of different VT mor-
phologies per patient ranging from 1.8 to 3.8 (Ellison et al.,
1998; O’Donnell et al., 2003). The number of different VTs in
AC patients was quantified and compared to a control group
after 8 years of follow-up (Cox et al., 2008). Multiple VT
morphologies were recorded in 27 of 42 AC patients (64%),
whereas the control group with idiopathic VT had only a single
morphology. This study confirmed that occurrence of multi-
ple VT morphologies is very common in AC patients. In case
only a single VT morphology occurred spontaneously, pro-
grammed electrical stimulation (PES) contributed to yield mul-
tiple morphologies. In total, 10 additional AC patients or in
total 88% fulfilled the multiple VT morphology criterion (Cox
et al., 2008). Because of overlap with the superior axis crite-
rion, the number of VT morphologies is not included in the
new TFC.
FIGURE 4 | Negative T waves in V1−5, recorded from AC patient with both a plakophilin2 mutation and a desmoglein2 mutation. Negative T waves in
V1−3 and beyond are a major criterion in the new Task Force criteria.
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FIGURE 5 | VT with LBBB morphology and superior axis, recorded from AC patient with plakophilin2 mutation. This morphology is a major criterion in
the new Task Force criteria.
FIGURE 6 | VT with LBBB morphology and inferior axis (minor criterion), recorded from AC patient without identified desmosomal gene mutation.
This morphology is not typical for AC and is also often recorded in patients with idiopathic VT.
VALIDATION OF ADDITIONAL ECG CRITERIA
Since sudden death frequently is the first manifestation of AC,
even already in adolescence, the main diagnostic challenge is
to identify individuals in an early concealed stage of the dis-
ease. We studied whether the previously proposed additional
ECG criteria would improve diagnosis in patients highly sus-
pected of AC, but who do not fulfilled the 1994 TFC for AC
diagnosis (Cox et al., 2009). The presence of the new additional
criteria was studied in so-called “probable” AC patients since they
fulfilled either only 1 major and 1minor, or only 3minor cri-
teria. We studied the diagnostic contribution of (1) prolonged
TAD in V1−3, (2) VT with LBBB morphology and superior axis,
and (3) recording of multiple VT morphologies. Two groups
were studied: Group A (n = 21) with probable but not proven
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AC index patients, and Group B (n = 12) consisting of fam-
ily members of 50 other proven (fulfilling 1994 TFC) AC index
patients.
In Group A, none had epsilon waves or QRS >110ms,
whereas prolonged TAD was recorded in 7 (33%) patients, there-
fore fulfilling AC diagnosis when this criterion was applied
additionally to 1994 TFC, and thus fulfilling the new 2010
TFC. In 8 Group A patients (38%) a spontaneously occur-
ring VT with LBBB morphology and superior axis has been
recorded. In addition, this morphology was inducible with
PES in 4 additional patients. In 4 Group A patients (19%)
multiple VT morphologies were recorded during spontaneous
episodes, and in 5 additional patients during PES. In total 16
of 21 Group A index patients did fulfil at least 1 of the new
criteria.
In Group B, one family member had epsilon waves, and 8
had prolonged TAD. Because of both absence of spontaneous VT
episode recordings and PES, VT criteria could not contribute to
diagnosis in Group B patients. However, in total 7 Group B family
members did fulfil new criteria.
SUMMARY
The 12-lead ECG is one of the most important tools for diagnosis
of AC. In addition this tool contributes to evaluation of pro-
gression of the disease during follow-up. Since in AC ventricular
arrhythmias and sudden death are due to re-entrant mechanisms,
activation delay is a critical component. Recently a new parame-
ter of activation delay, prolonged TAD, appeared to be superior in
sensitivity compared to previously defined activation delay crite-
ria, without loss of specificity. In addition, repolarization and new
VT criteria contribute importantly to AC diagnosis.
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